← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2009Last known activity
Jul 1, 2024
Timeline
1970s
- Oct 1, 1977
Hospital Universitario Ramon y Cajal— Founded
Drugs by trial phase (34 distinct, 18 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Aspergillosis
- Asthma
- Colorectal Neoplasms
- Communicable Diseases
- Cystic Fibrosis
- Fibrosis
- Heart Failure
- HIV Infections
- Infections
- Inflammation
- Invasive Pulmonary Aspergillosis
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Pulmonary Aspergillosis
- Renal Insufficiency
- Shock
- Shock, Cardiogenic
Recent trials (25)
- NCT06258850CollaboratorPhase 4Jul 1, 2024
- NCT05781243CollaboratorPhase 4Jun 19, 2023
- NCT05673811OfficialPhase 2Jan 10, 2023
- NCT05201079Overall official - principal investigatorPhase 3Oct 29, 2021
- NCT05754242Lead sponsorPhase 2Nov 17, 2020
- NCT05754242Reponsible party - principal investigatorPhase 2Nov 17, 2020
- NCT04382066Overall official - principal investigatorPhase 1May 12, 2020
- NCT04435717Reponsible party - principal investigatorPhase 2May 4, 2020
- NCT04435717Lead sponsorPhase 2May 4, 2020
- NCT04271839Overall official - principal investigatorPhase 4Apr 30, 2020
- NCT04160546Overall official - principal investigatorPhase 2Dec 2, 2019
- NCT04267497Study chairPhase 1Oct 18, 2019
- NCT04076423Overall official - principal investigatorPhase 4Sep 15, 2019
- NCT04043676Overall official - principal investigatorPhase 2Apr 30, 2019
- NCT03635021Study chairPhase 3Sep 15, 2018
Details
- Founded
- Madrid, ES Oct 1, 1977
- Last known activity
- Jul 1, 2024